CN117136410A - 用于预测肿瘤特异性新抗原mhc i类或ii类免疫原性的深度学习模型 - Google Patents

用于预测肿瘤特异性新抗原mhc i类或ii类免疫原性的深度学习模型 Download PDF

Info

Publication number
CN117136410A
CN117136410A CN202180095858.9A CN202180095858A CN117136410A CN 117136410 A CN117136410 A CN 117136410A CN 202180095858 A CN202180095858 A CN 202180095858A CN 117136410 A CN117136410 A CN 117136410A
Authority
CN
China
Prior art keywords
tumor
peptide
mhc class
specific
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180095858.9A
Other languages
English (en)
Chinese (zh)
Inventor
吉尔·萨德
大卫·赫克曼
莱恩·克里斯托弗·普莱斯
弗兰克·威廉·施米茨
安塔·伊马塔·萨福
贾斯林·考尔·格鲁沃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amazon Technologies Inc
Original Assignee
Amazon Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amazon Technologies Inc filed Critical Amazon Technologies Inc
Publication of CN117136410A publication Critical patent/CN117136410A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/044—Recurrent networks, e.g. Hopfield networks
    • G06N3/0442—Recurrent networks, e.g. Hopfield networks characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU]
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/0499—Feedforward networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/082—Learning methods modifying the architecture, e.g. adding, deleting or silencing nodes or connections
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/0895—Weakly supervised learning, e.g. semi-supervised or self-supervised learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/09—Supervised learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/096—Transfer learning
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Computational Linguistics (AREA)
  • Computing Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioethics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202180095858.9A 2021-01-19 2021-12-01 用于预测肿瘤特异性新抗原mhc i类或ii类免疫原性的深度学习模型 Pending CN117136410A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163139074P 2021-01-19 2021-01-19
US63/139,074 2021-01-19
PCT/US2021/061399 WO2022159176A1 (en) 2021-01-19 2021-12-01 A deep learning model for predicting tumor-specific neoantigen mhc class i or class ii immunogenicity

Publications (1)

Publication Number Publication Date
CN117136410A true CN117136410A (zh) 2023-11-28

Family

ID=80122521

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180095858.9A Pending CN117136410A (zh) 2021-01-19 2021-12-01 用于预测肿瘤特异性新抗原mhc i类或ii类免疫原性的深度学习模型

Country Status (5)

Country Link
US (1) US12567480B2 (https=)
EP (1) EP4281970A1 (https=)
JP (1) JP2024505638A (https=)
CN (1) CN117136410A (https=)
WO (1) WO2022159176A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117877603A (zh) * 2024-01-11 2024-04-12 天津大学 一种基于分层信息提取机制的化学反应理论产量预测方法
CN119152945A (zh) * 2024-10-08 2024-12-17 中国人民解放军海军军医大学第一附属医院 一种NeoBert模型及其在鉴别肿瘤新抗原中的应用
CN119964812A (zh) * 2025-04-10 2025-05-09 成都大学附属医院(成都市创伤骨科研究所) 基于深度学习的前列腺癌医学智能预测系统
CN120048333A (zh) * 2025-02-14 2025-05-27 三二〇一医院 一种新抗原的筛选方法、设备及程序产品

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116959581A (zh) * 2023-01-17 2023-10-27 腾讯科技（深圳）有限公司 免疫原性预测模型的训练方法、装置、设备及存储介质
KR20250058439A (ko) * 2023-10-23 2025-04-30 주식회사 Lg 경영개발원 비관측 단백질 복합체를 활용하여 항원 제시 모델을 생성하는 단백질 상호 작용 예측 장치 및 이를 이용한 방법
WO2025128926A1 (en) 2023-12-13 2025-06-19 Amazon Technologies, Inc. Methods of identifying and treating individuals with elevated cancer risk
US20250197924A1 (en) 2023-12-15 2025-06-19 Amazon Technologies, Inc. Methods for selection and combination of sequencing results from biological samples for neoantigen scoring
WO2026072916A1 (en) 2024-09-30 2026-04-02 Amazon Technologies, Inc. Structural variant detection in circulating tumor dna
WO2026073127A1 (en) 2024-09-30 2026-04-02 Amazon Technologies, Inc. Dual assay to boost accuracy of detected actionable variants in liquid biopsy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170199961A1 (en) * 2015-12-16 2017-07-13 Gritstone Oncology, Inc. Neoantigen Identification, Manufacture, and Use
CN111868080A (zh) * 2018-02-27 2020-10-30 磨石肿瘤生物技术公司 利用泛等位基因模型进行的新抗原鉴别
CN112002374A (zh) * 2020-06-14 2020-11-27 北京臻知医学科技有限责任公司 基于深度学习的mhc-i表位亲和力预测方法
CN112071361A (zh) * 2020-04-11 2020-12-11 信华生物药业(广州)有限公司 基于Bi-LSTM与Self-Attention的多肽TCR免疫原性预测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US8063063B2 (en) 2006-03-23 2011-11-22 Novartis Ag Immunopotentiating compounds
ES2536426T3 (es) 2006-03-23 2015-05-25 Novartis Ag Compuestos de imidazoquinoxalina como inmunomoduladores
EP3930755A4 (en) * 2019-03-01 2023-03-22 Flow Pharma Inc. DESIGN, MANUFACTURE AND USE OF PERSONALIZED CANCER VACCINES
EP3739589A1 (en) * 2019-05-17 2020-11-18 NEC OncoImmunity AS Method and system for binding affinity prediction and method of generating a candidate protein-binding peptide
CN111415707B (zh) * 2020-03-10 2023-04-25 四川大学 临床个体化肿瘤新抗原的预测方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170199961A1 (en) * 2015-12-16 2017-07-13 Gritstone Oncology, Inc. Neoantigen Identification, Manufacture, and Use
CN111868080A (zh) * 2018-02-27 2020-10-30 磨石肿瘤生物技术公司 利用泛等位基因模型进行的新抗原鉴别
CN112071361A (zh) * 2020-04-11 2020-12-11 信华生物药业(广州)有限公司 基于Bi-LSTM与Self-Attention的多肽TCR免疫原性预测方法
CN112002374A (zh) * 2020-06-14 2020-11-27 北京臻知医学科技有限责任公司 基于深度学习的mhc-i表位亲和力预测方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TIMOTHY J. O’DONNELL ET AL.WET: "MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing", 《CELL SYSTEMS》, 1 July 2020 (2020-07-01), pages 42 - 48 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117877603A (zh) * 2024-01-11 2024-04-12 天津大学 一种基于分层信息提取机制的化学反应理论产量预测方法
CN119152945A (zh) * 2024-10-08 2024-12-17 中国人民解放军海军军医大学第一附属医院 一种NeoBert模型及其在鉴别肿瘤新抗原中的应用
CN120048333A (zh) * 2025-02-14 2025-05-27 三二〇一医院 一种新抗原的筛选方法、设备及程序产品
CN120048333B (zh) * 2025-02-14 2025-10-21 三二〇一医院 一种新抗原的筛选方法、设备及程序产品
CN119964812A (zh) * 2025-04-10 2025-05-09 成都大学附属医院(成都市创伤骨科研究所) 基于深度学习的前列腺癌医学智能预测系统

Also Published As

Publication number Publication date
EP4281970A1 (en) 2023-11-29
JP2024505638A (ja) 2024-02-07
WO2022159176A1 (en) 2022-07-28
US20230074591A1 (en) 2023-03-09
US12567480B2 (en) 2026-03-03

Similar Documents

Publication Publication Date Title
US12567480B2 (en) Deep learning model for predicting tumor-specific neoantigen MHC class I or class II immunogenicity
JP7530455B2 (ja) 新生抗原の特定、製造、及び使用
JP7755628B2 (ja) 新生抗原のためのジャンクションエピトープ提示の低減
JP7651623B2 (ja) 新生抗原の特定、製造、及び使用
JP2025065197A (ja) 新生抗原の特定、製造、および使用
JP2024508677A (ja) 個別化がんワクチン用ネオアンチゲンのランク付け
US20220122690A1 (en) Attention-based neural network to predict peptide binding, presentation, and immunogenicity
Safavi et al. In silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer
US20170028044A1 (en) Compositions And Methods For Viral Cancer Neoepitopes
Brennick et al. An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection
CA3217623A1 (en) Compositions and method for optimized peptide vaccines using residue optimization
Polyakova et al. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens
CN117321690A (zh) 用于优化肿瘤疫苗抗原对异质性恶性肿瘤的覆盖的方法
Rähni et al. Melanoma-specific antigen-associated antitumor antibody reactivity as an immune-related biomarker for targeted immunotherapies
Nakahara et al. Prospects for a personalized peptide vaccine against lung cancer
JP2023540851A (ja) ネオペプチトープ含有ワクチン剤の製造方法
US11920202B2 (en) Unbiased identification of tumor rejection mediating neoepitopes
JP2025509806A (ja) フォローアップネオ抗原がんワクチンのサブクローン透過を改善するための循環腫瘍ｄｎａのモニタリング
González-Cao et al. Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients
Tarabini et al. Mutations in glioblastoma proteins do not disrupt epitope presentation and recognition, maintaining a specific CD8 T cell immune response potential
Khodadadi et al. Design and in vivo evaluation of a multi-epitope vaccine that suppresses tumour growth in a murine colorectal cancer model
Kashyap et al. In silico design and immunoinformatics evaluation of a multi-epitope vaccine targeting SEPT9 for gastrointestinal adenocarcinomas
Rao Prediction of T-Cell Epitopes for Cancer Therapy
Alexander CD8-based T cell vaccination and CD4 T cell responses in prostate cancer
Ghesmati Immunoinformatics based designing of a multi-epitope peptide vaccine candidate against prostate cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination